The largest database of trusted experimental protocols

Hrp conjugated and fluorophore conjugated secondary antibodies

Manufactured by Jackson ImmunoResearch

HRP-conjugated and fluorophore-conjugated secondary antibodies are laboratory reagents used in various immunoassay techniques. They are designed to bind and detect primary antibodies, enabling signal amplification and visualization for analytical purposes. These conjugated antibodies serve as essential tools in applications such as Western blotting, ELISA, and immunohistochemistry.

Automatically generated - may contain errors

3 protocols using hrp conjugated and fluorophore conjugated secondary antibodies

1

Comprehensive Immunofluorescence Antibody Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and dilutions used were mouse anti-Ptc antibody 1:50 (DSHB, Apa1; 1/50); rat anti-Ci antibody 1:50 (DSHB, 2A1; 1/50); rabbit anti-Dpp prodomain (Akiyama and Gibson, 2015 (link); 1/100); rabbit anti-GFP (Invitrogen, A-11122; 1/1000); chicken anti-GFP (Abcam Cat# ab13970; 1/2000); rabbit anti-phospho-Smad1/5 (Ser463/465) (Cell Signaling Technology, 9516; 1/100); mouse anti-HA.11 (Covance, Cat#101P; 1/1000); rabbit anti-HA (Thermo Fisher Scientific, Cat# 71-5500; 1/1000); mouse anti-β-tubulin (DSHB, E7; 1/5000); mouse anti-β-galactosidase (Promega, Z378A; 1/100); mouse anti-Myc (Santa Cruz Biotechnology, 9E10; 1/200); mouse anti-FLAG (Sigma-Aldrich, M2; 1/200); rabbit anti-FLAG (Sigma-Aldrich, Cat# F7425; 1/200); HRP-conjugated and fluorophore-conjugated secondary antibodies were from Jackson ImmunoResearch Lab and Thermo Fisher. The antibody information is also listed in the Key resources table.
+ Open protocol
+ Expand
2

Ubiquitination Pathway Regulation in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primers were synthesized and PAGE purified by IDT DNA. Fugene 6 transfection reagent was purchased from Promega while Lipofectamine RNAiMax was from Life Technologies/Invitrogen. All cell culture reagents including media, antibiotics were from GIBCO/Invitrogen. Antibodies to total Ubiquitin (clone P4D1) was from Santacruz Biotechnology, Luciferase (Millipore), pAKT, AKT (Cell Signaling), Ubiquitin, Lys63 specific (clone Apu3, Millipore), His-tag (clone H3 and C-term, Invitrogen) or Millipore (H8 clone). FLAG tag-HRP antibody (Clone M2) was purchased from Sigma Aldrich. HRP-conjugated and fluorophore-conjugated secondary antibodies were from Jackson ImmunoResearch. ON-TARGET plus siRNA to TRAF6 and scrambled control siRNA were obtained from GE Life Sciences/Dharmacon. D-Luciferin was from Xenogen Corp while GloSensor was from Promega. Erlotinib was a kind gift from Genentech. Tyrphostin AG1478 was obtained from Cayman Chemical. TNF-α antagonist (WP9QY) and IL-1R antagonist were from SantaCruz biotechnology. Recombinant IGF-1, IL-1α were from PepreoTech. CI-1040, GF109203X, NVP-AEW541 and MK2206 (Cayman Chemical), and Linsitinib (LC Laboratories). Protein A and Protein G sepharose beads were from GE HealthCare. Purified NEDD4-1 (Sigma Aldrich), Myc-tagged ubiquitin (Cat. No. U-115) UBE1 (Cat. No. E305), and UBCH5 (Cat. No. E2-616) all were from Boston Biochemicals.
+ Open protocol
+ Expand
3

Kinase Inhibitors for TGF-beta Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies to phosphorylated (pSer465/467) or total SMAD2, TGFBRI, TGFBRII, pSer63 c-JUN, pSer473 or total AKT, pThr180/Tyr182 or total p38MAPK, and GAPDH were all from Cell Signaling Technology. Antibody against SMAD3 was from Invitrogen; antibodies to TGFBR1 (H100) and TGFBRII (L21) were from Santa Cruz; antibodies to Myc-tag and firefly luciferase were from Millipore; antibodies to N-terminal of BUB1 were from Abcam (rabbit) or Santa Cruz (goat); antibody to Flag-HRP was from Sigma; and antibodies to His-HRP were from Invitrogen (clones H3 and C-term) or Millipore (H8 clone). HRP-conjugated and fluorophore-conjugated secondary antibodies were from Jackson ImmunoResearch. Recombinant human TGFβ1 was obtained from HumanZyme. TGFBRI inhibitor SB431542 was obtained from Cayman Chemical. D-Luciferin was from Xenogen Corp. The siGENOME Smart Pool siRNA library targeted against all human kinases, non-silencing siRNA (NSS), and individual siRNA from the siGENOME Smart Pool, and custom siRNA against BUB1 were obtained from Dharmacon. A specific, small molecule inhibitor of BUB1 kinase activity (2-[(4-amino-1-(tert-butyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)methyl]phenol; (2OH-BNPP1) (9 (link)) was synthesized in house.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!